Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Huwate Yeerna
Affiliation
Moores Cancer Center, University of California
ORCID
Career Start Year
2015
Papers
14
H Index
12
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
34376580
KIT<sup>low</sup> Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.
Mol Cancer Ther
2021
32525984
Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples.
Nucleic Acids Res
2020
31913126
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
Elife
2020
32530570
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.
Mol Oncol
2020
31171722
Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
J Biol Chem
2019
31582393
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes.
Blood Adv
2019
31292160
Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Cancer Res
2019
30583461
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
Cancers (Basel)
2018
29985391
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
Nat Commun
2018
30723579
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy.
Oncoimmunology
2018
28837809
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.
Cell Syst
2017
27453043
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
Mol Cell
2016
25854185
Effect of Diabetes Mellitus on Adipocyte-Derived Stem Cells in Rat.
J Cell Physiol
2015
26437225
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Oncotarget
2015
1 - 14 of 14
Column Actions
Search
Recommended Authors
Rohan Bareja
Case Western Reserve University
Career Start Year
2017
Number of shared co-authors
0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Matan Hofree
Broad Institute of Harvard and MIT
Career Start Year
2010
Number of shared co-authors
13
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year
2008
Number of shared co-authors
0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
2
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
4
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2006
Number of shared co-authors
3
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
5
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
1
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
2
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
3
Habib Hamidi
Genentech Inc.
Career Start Year
2002
Number of shared co-authors
0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
0
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
3
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year
2001
Number of shared co-authors
2
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
0
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
0
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
7
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
2
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
3
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
8
row(s) 1 - 30 of 30
Collaborators
Pablo Tamayo
University of California San Diego
Co-authored papers
11
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
3
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers
3
Jill P Mesirov
University of California San Diego
Co-authored papers
2
Su Ming Sun
Leiden University Medical Center
Co-authored papers
2
Jianfeng Li
Mitchell Cancer Institute, University of South Alabama
Co-authored papers
2
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Co-authored papers
2
Kristin Klepper
University of California San Diego
Co-authored papers
2
Rafael Bejar
Moores Cancer Center, university of california san diego
Co-authored papers
2
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
2
Vignesh Sivaganesh
University of the Sciences
Co-authored papers
2
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Katherine Licon
University of California San Diego
Co-authored papers
2
Robert W Sobol
University of South Alabama
Co-authored papers
2
Rohith Srivas
Amgen Inc.
Co-authored papers
2
Haico van Attikum
Leiden University Medical Center
Co-authored papers
2
Jia L Xu
Stem Cell Program and Institute for Genomic Medicine, University of California
Co-authored papers
2
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers
2
Daniel Pekin
University of California
Co-authored papers
2
Andrew M Gross
Illumina Inc.
Co-authored papers
2
Ana Bojorquez-Gomez
University of California
Co-authored papers
2
Joshua Chiou
Co-authored papers
1
Chen-Hsiang Yeang
Institute of Statistical Science
Co-authored papers
1
Kun-Liang Guan
University of California San Diego
Co-authored papers
1
Aravind Subramanian
Co-authored papers
1
Yusuke Goto
Chiba University Graduate School of Medicine
Co-authored papers
1
Jesse S Boehm
Broad Institute of Harvard and MIT
Co-authored papers
1
Arthur Liberzon
Broad Institute of MIT and Harvard
Co-authored papers
1
Dinh Diep
Co-authored papers
1
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
1
1 - 30